Discovery of 1-(4-(5-(5-amino-6-(5-tert-butyl-1,3,4-oxadiazol-2-yl)pyrazin-2-yl)-1-ethyl-1,2,4-triazol-3-yl)piperidin-1-yl)-3-hydroxypropan-1-one (AZD8835): A potent and selective inhibitor of PI3Kα and PI3Kδ for the treatment of cancers

Published 2015 View Full Article

Authors

Keywords

PI3Kα, PI3Kδ, Kinase, PIK3CA mutation

Journal

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Volume 25, Issue 22, Pages 5155-5162

Publisher

Elsevier BV

Online

2015-10-16

DOI

10.1016/j.bmcl.2015.10.002

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started